SEMAX 10MG
Semax 10MG is a defined synthetic research peptide supplied exclusively for controlled laboratory and analytical investigations involving molecular characterization, neuropeptide-associated signaling pathways, cellular regulatory mechanisms, peptide stability, and experimental biochemical research.
Research Context
Semax is a synthetic seven-amino-acid peptide derived from the adrenocorticotropic hormone (ACTH) fragment 4-7, extended with the Pro-Gly-Pro sequence. It is studied in laboratory research involving neurobiological signaling, neurotrophic factor-associated molecular pathways, cellular communication mechanisms, and peptide-mediated biochemical interactions. Its defined molecular structure supports controlled investigations of neuropeptide characteristics, gene expression-associated processes, and experimental neurological signaling models. Semax is also examined in preclinical research involving neuronal cellular responses, oxidative stress-associated pathways, and neurobiological molecular regulation.
Laboratory Research Information
Laboratory studies may examine molecular identification, peptide stability, neuropeptide-associated signaling pathways, cellular regulatory processes, and experimental assay behavior. Research may also involve analytical characterization, chromatographic separation, neurotrophic factor-associated molecular mechanisms, gene expression studies, and compound-specific biochemical interactions under controlled conditions. Investigations may further evaluate peptide structure-function relationships and interactions with experimental neuronal cellular systems. Observations should be interpreted within the design and limitations of the relevant experimental study, without assuming established clinical effectiveness.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | SEMAX 10MG |
| Brand | Soltovia |
| Alternative Name | ACTH (4-7)-PGP / Met-Glu-His-Phe-Pro-Gly-Pro |
| Compound Type | Synthetic linear heptapeptide research compound |
| Research Profile | Neuropeptide signaling, neurobiological molecular pathways, and cellular regulatory research |
| Molecular Weight | 813.93 Da (reference free-acid form) |
| Monoisotopic Mass | 813.34796 Da (reference free-acid form) |
| Molecular Formula | C37H51N9O10S (reference free-acid form) |
| CAS Number | 80714-61-0 |
| PubChem CID | 9811102 |
| Amino Acid Count | 7 |
| Amino Acid Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Single-Letter Sequence | MEHFPGP |
| Structural Characteristics | Linear ACTH-derived heptapeptide with a C-terminal Pro-Gly-Pro extension |
| Research Classification | Synthetic neuropeptide research compound |
| Research Pathways | Neuropeptide-associated signaling, neurotrophic factor-related molecular processes, cellular regulation, and gene expression research |
| Available Size | 10MG |
| Purity | Refer to batch-specific COA |
| Testing Method | Refer to batch-specific COA |
| Laboratory | Refer to batch-specific COA |
For laboratory research use only. Not for human or veterinary use. This material does not provide medical or consumer-use guidance.
Reviews
There are no reviews yet.